OXIPLEX/AP/INTERCOAT/INTERPOSE
Adhesion prevention in abdominal/pelvic surgery
ApprovedCommercial
Key Facts
Indication
Adhesion prevention in abdominal/pelvic surgery
Phase
Approved
Status
Commercial
Company
About FzioMed
FzioMed is a long-standing, privately-held medical device company focused on the surgical adhesion prevention market. Its commercialized product portfolio is built on a proprietary dual-polymer gel technology (CMC/PEO) that acts as a physical barrier to reduce adhesion formation. With over two decades of clinical use, treatment of more than one million patients, and peer-reviewed evidence across several surgical areas, the company is an established player in a niche but critical segment of surgical care. It operates primarily through a distributor network to market its approved products globally.
View full company profile